The Flagship

Give 100 · The Sovereign Shield · QE2C

Queen Elizabeth II Centre
for Cervical Cancer Elimination

The founding flagship of the Institute of Preemptology—a practical demonstration of Preemptology in one disease where elimination is already scientifically possible.

One cancer. Preventable. Eliminable.
Legacy

A Legacy of Cancer Advocacy

Her long association with cancer care and research gives the Queen Elizabeth II Centre for Cervical Cancer Elimination its moral lineage. Her centenary gives the Commonwealth observance its symbolic occasion. QE2C turns tribute into institutional consequence. The lineage that now reaches Enugu begins at The Royal Marsden in 1952.

3 June 1952 Queen Elizabeth II became Patron of The Royal Marsden—the world’s first hospital dedicated to cancer treatment and research. In 1954, she granted it the Royal name. Her patronage helped move cancer from silence to science.
From 1953 She served as Patron of the organisations that later formed Cancer Research UK—her name associated for decades with laboratories advancing prevention, early detection, and improved control.
Across Her Reign Her reign witnessed the modern rise of organised cervical cancer screening—from early, uneven efforts to national programmes with reliable invitations, follow-up, and quality control.
Her Centenary That lineage now extends to a new prevention initiative in the Global South—one that donors in Toronto understand and communities in Enugu can trust. QE2C is the institutional expression of that continuity.

Cervical cancer is a systems problem. Her steady, duty-bound presence in cancer patronage makes her an emblem of the long-horizon institutional commitment that elimination requires. What stops elimination is the gap between what is solvable and what is institutionally owned. The Institute of Preemptology is designed to close that gap.

Proof

One Cancer We End Now

Preemptology is the discipline of eliminating the preventable aspect of disease—through every level of prevention, across every demographic, and at every scale. Within that mandate, one disease leads first: a 100% preventable cancer should not kill. The correct disease to begin with is the one that proves the system.

Cervical cancer is chosen not because the Institute of Preemptology is a cancer-only project, but because it is preventable, eliminable, measurable, inequitable, and urgent. It is the disease that proves the system. Its continued toll is the direct consequence of prevention that is not operationally owned.

~350,000 Lives Lost
Every Year
~1,000 Deaths
Every Day
~95% Occurring in
LMICs

QE2C is the founding flagship of the Institute of Preemptology—chosen because it is fully preventable, globally neglected, and structurally solvable. The Institute of Preemptology brings together the training pipeline, mobile health systems, Preemptive Health Zones, and the institutional infrastructure needed to make prevention operationally owned. When the system works for cervical cancer, it proves the model for every preventable burden that follows.

‘We are building this infrastructure so that a mother in her forties never again has to be rushed into a mission hospital emergency room, dying from a late-stage cervical cancer that a routine screening could have stopped years earlier.’

— Dr. Abia Nzelu, Secretary-General, Givingtide International
Equity

For the Women the World Overlooks

‘A woman in Malawi faces a risk of dying from cervical cancer up to 50 times higher than a woman in Canada. Both are Commonwealth citizens.’

Cervical cancer persists, in part, because the women it kills are overlooked. Their deaths do not command the urgency that other tragedies do. That is the gap the Queen Elizabeth II Centre for Cervical Cancer Elimination—QE2C—exists to close.

~⅓ of the world’s population lives in Commonwealth nations
>40% of annual global cervical cancer deaths fall within the Commonwealth
9/9 of the nations with the highest cervical cancer death rates are Commonwealth members
~150,000 Commonwealth women lost every year to a preventable disease

The burden is dispersed enough to ignore and concentrated enough to eliminate.

Queen Elizabeth II’s reign made female authority visible at the pinnacle of power for seven decades. In 2011, she gave royal assent to the end of male-preference succession for the first time in 1,000 years. Her centenarian messages honoured every life equally.

QE2C declares what her reign embodied: women’s lives command institutional priority.

This Centre says, as those messages did: we see you.

A Commonwealth of nations becoming a common wealth of years.
Precedent

The Pattern Is Proven

The problem is not science. The problem is ownership and coordination. Where organised prevention exists, incidence and mortality can fall dramatically. The strategy is already proven. Several of the countries leading the world toward cervical cancer elimination have a direct Queen Elizabeth II or Commonwealth connection.

Australia Ranked 1st
First globally in full implementation of the elimination strategy—and the nation where the HPV vaccine was developed.
United Kingdom Ranked 4th
The first vaccinated cohorts have seen a 90% fall in cervical cancer rates—a proof of strategy with direct Commonwealth resonance.
Rwanda First LMIC
First low- and middle-income country to introduce the HPV vaccine. Welcomed into the Commonwealth in 2009, during Queen Elizabeth II’s reign, as its first member with no British colonial past.

Where organised prevention exists, mortality falls fast. The evidence is established. The Institute of Preemptology—advanced through Give 100 and the Sovereign Shield—scales that combination to the Commonwealth nations where the burden is greatest.

When prevention is owned, coordinated, and measured, elimination becomes procedural.

Her seven decades of public service and cancer patronage now find centenary expression in prevention at scale. Through Give 100, the Sovereign Shield turns Commonwealth tribute into a permanent institution: the Institute of Preemptology, with QE2C as its founding flagship.

Give 100  ·  The Sovereign Shield  ·  21.09.2026 — 21.09.2027